US7157555B1
(en)
*
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
CA2510893C
(en)
|
2002-12-20 |
2012-07-10 |
Amgen, Inc. |
Binding agents which inhibit myostatin
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
ATE497783T1
(de)
|
2003-05-06 |
2011-02-15 |
Syntonix Pharmaceuticals Inc |
Gerinnungsfaktor vii-fc chimäre proteine zur behandlung von hämostatischen krankheiten
|
CA2536918A1
(en)
|
2003-08-26 |
2005-03-03 |
Leland Shapiro |
Compositions of, and methods for, alpha-1 antitrypsin fc fusion molecules
|
KR101135244B1
(ko)
*
|
2007-11-29 |
2012-04-24 |
한미사이언스 주식회사 |
인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물
|
JP4870569B2
(ja)
*
|
2003-11-13 |
2012-02-08 |
ハンミ ホールディングス カンパニー リミテッド |
免疫グロブリン断片を用いた蛋白質結合体およびその製造方法
|
US8263084B2
(en)
*
|
2003-11-13 |
2012-09-11 |
Hanmi Science Co., Ltd |
Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
ES2365023T3
(es)
*
|
2004-04-21 |
2011-09-20 |
Enobia Pharma Inc. |
Conjugados de administración ósea y método de uso de los mismos para dirigir proteínas a hueso.
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
EP1773400A2
(en)
*
|
2004-07-08 |
2007-04-18 |
Amgen Inc. |
Therapeutic peptides
|
KR100594607B1
(ko)
*
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
CA2592015A1
(en)
*
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
CA2597346A1
(en)
*
|
2005-02-14 |
2006-08-17 |
Apollo Life Sciences Limited |
A molecule and chimeric molecules thereof
|
KR100754667B1
(ko)
*
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Fc 단편 및이를 포함하는 약제학적 조성물
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
EP2298815B1
(en)
|
2005-07-25 |
2015-03-11 |
Emergent Product Development Seattle, LLC |
B-cell reduction using CD37-specific and CD20-specific binding molecules
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
KR100824505B1
(ko)
*
|
2005-08-16 |
2008-04-22 |
한미약품 주식회사 |
개시 메티오닌 잔기가 제거된 면역글로불린 Fc 영역의대량 생산방법
|
CN101258164B
(zh)
*
|
2005-08-16 |
2013-05-01 |
韩美科学株式会社 |
用于大量生产缺失起始甲硫氨酸残基的免疫球蛋白Fc区的方法
|
CN101534865A
(zh)
*
|
2005-10-19 |
2009-09-16 |
Ibc药品公司 |
生物活性装配体的制备方法及其用途
|
EP1945262A2
(en)
*
|
2005-10-20 |
2008-07-23 |
The Scripps Research Institute |
Fc labeling for immunostaining and immunotargeting
|
TW200732350A
(en)
*
|
2005-10-21 |
2007-09-01 |
Amgen Inc |
Methods for generating monovalent IgG
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
CA2631184A1
(en)
|
2005-11-28 |
2007-05-31 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
AU2006321906C1
(en)
*
|
2005-12-06 |
2014-01-16 |
Amgen Inc. |
Uses of myostatin antagonists
|
CN101002945B
(zh)
|
2006-01-20 |
2012-09-05 |
清华大学 |
一种用于肿瘤治疗的新型复合物
|
CN100475270C
(zh)
|
2006-01-20 |
2009-04-08 |
清华大学 |
一种治疗肿瘤的药物及其应用
|
KR101571027B1
(ko)
*
|
2006-06-12 |
2015-11-23 |
이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 |
효과기 기능을 갖는 단일쇄 다가 결합 단백질
|
MX2009002014A
(es)
*
|
2006-08-28 |
2009-03-09 |
Ares Trading Sa |
Proceso para la purificacion de proteinas que contienen fc.
|
US20140147441A1
(en)
*
|
2006-09-12 |
2014-05-29 |
The General Hospital Corporation |
Compositions containing alpha-1-antitrypsin and methods for use
|
AU2007343796A1
(en)
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
US20080181903A1
(en)
*
|
2006-12-21 |
2008-07-31 |
Pdl Biopharma, Inc. |
Conjugate of natriuretic peptide and antibody constant region
|
JP2008169195A
(ja)
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
CN101219219B
(zh)
|
2007-01-10 |
2013-02-13 |
北京普罗吉生物科技发展有限公司 |
包含血管抑素或其片段的复合物、其制备方法及应用
|
US20080238882A1
(en)
*
|
2007-02-21 |
2008-10-02 |
Ramesh Sivarajan |
Symmetric touch screen system with carbon nanotube-based transparent conductive electrode pairs
|
WO2013106175A1
(en)
|
2011-12-19 |
2013-07-18 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
TWI573802B
(zh)
|
2007-03-06 |
2017-03-11 |
安美基公司 |
變異之活動素受體多肽及其用途
|
MX2009012609A
(es)
|
2007-05-22 |
2009-12-07 |
Amgen Inc |
Composiciones y metodos para producir proteinas de fusion bioactivas.
|
CN101687933B
(zh)
*
|
2007-05-30 |
2015-11-25 |
浦项工科大学校产学协力团 |
免疫球蛋白融合蛋白
|
EP2167669A2
(en)
*
|
2007-05-31 |
2010-03-31 |
Genmab A/S |
Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
|
PL2185589T3
(pl)
|
2007-06-01 |
2016-09-30 |
|
Środki wiążące receptor regionu stałego Fc immunoglobuliny
|
US20100310561A1
(en)
*
|
2007-06-06 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Natriuretic fusion proteins
|
KR20100044160A
(ko)
*
|
2007-06-12 |
2010-04-29 |
와이어쓰 엘엘씨 |
항-cd20 치료 조성물 및 방법
|
US20090148447A1
(en)
*
|
2007-07-06 |
2009-06-11 |
Trubion Pharmaceuticals, Inc. |
Binding Peptides Having a C-terminally Disposed Specific Binding Domain
|
US8492347B2
(en)
*
|
2007-10-17 |
2013-07-23 |
The Regents Of The University Of California |
Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus
|
CN101918027A
(zh)
*
|
2007-11-02 |
2010-12-15 |
森托科尔奥索生物科技公司 |
半合成GLP-1肽-Fc融合构造、方法及其用途
|
WO2009126944A1
(en)
*
|
2008-04-11 |
2009-10-15 |
Trubion Pharmaceuticals, Inc. |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
MY151184A
(en)
|
2008-07-23 |
2014-04-30 |
Hanmi Science Co Ltd |
A polypeptide complex comprising non-peptidyl polymer having three functional ends
|
RU2457856C2
(ru)
*
|
2008-08-05 |
2012-08-10 |
Виктор Владимирович Чалов |
Композиция, обладающая противовирусным и антимикробным действием, для перорального применения
|
WO2010016944A2
(en)
*
|
2008-08-07 |
2010-02-11 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
|
CN103641906A
(zh)
|
2008-08-07 |
2014-03-19 |
益普生制药股份有限公司 |
葡萄糖依赖性促胰岛素多肽类似物
|
CN104829706A
(zh)
*
|
2008-08-07 |
2015-08-12 |
益普生制药股份有限公司 |
糖依赖性胰岛素释放肽的类似物
|
EP2350118B1
(en)
*
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
EP2334335A1
(en)
*
|
2008-09-19 |
2011-06-22 |
Nektar Therapeutics |
Polymer conjugates of cd-np peptides
|
WO2010051335A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Amgen Inc. |
Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
|
SG171813A1
(en)
|
2008-11-26 |
2011-07-28 |
Amgen Inc |
Variants of activin iib receptor polypeptides and uses thereof
|
US20100143353A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Mosser David M |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
|
US20100158893A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Baxter International Inc. |
Systems and methods for obtaining immunoglobulin from blood
|
WO2010082804A2
(en)
*
|
2009-01-19 |
2010-07-22 |
Hanmi Pharm. Co., Ltd. |
Method for producing physiologically active protein or peptide using immunoglobulin fragment
|
US9238878B2
(en)
|
2009-02-17 |
2016-01-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
KR20110122134A
(ko)
|
2009-02-25 |
2011-11-09 |
머크 샤프 앤드 돔 코포레이션 |
글리코공학처리된 효모 피키아 파스토리스에서 갈락토스 동화 경로의 대사 공학
|
US20120142593A1
(en)
*
|
2009-03-24 |
2012-06-07 |
Bayer Healthcare Llc |
Factor VIII Variants and Methods of Use
|
EP2423233B1
(en)
|
2009-04-22 |
2015-03-11 |
Alteogen, Inc |
In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
|
US20120219538A1
(en)
*
|
2009-11-02 |
2012-08-30 |
Therapeomic Ag |
Stabilized protein formulations and use thereof
|
US8765432B2
(en)
|
2009-12-18 |
2014-07-01 |
Oligasis, Llc |
Targeted drug phosphorylcholine polymer conjugates
|
US9629920B2
(en)
|
2009-12-18 |
2017-04-25 |
Exodos Life Sciences Limited Partnership |
Methods and compositions for stable liquid drug formulations
|
RU2682720C2
(ru)
*
|
2010-01-19 |
2019-03-21 |
Ханми Сайенс Ко., Лтд. |
Жидкие составы для конъюгата эритропоэтина длительного действия
|
BR112012017979B1
(pt)
|
2010-01-19 |
2021-10-13 |
Hanmi Science Co., Ltd. |
Formulações líquidas para conjugado de g-csf de ação prolongada
|
WO2011093470A1
(ja)
*
|
2010-01-28 |
2011-08-04 |
協和発酵キリン株式会社 |
Bone morphogenetic protein receptor 1B(BMPR1B)細胞外ドメイン又はその変異体を含む蛋白質を含有する骨疾患治療用医薬組成物
|
KR101930961B1
(ko)
|
2010-02-24 |
2018-12-19 |
머크 샤프 앤드 돔 코포레이션 |
피키아 파스토리스에서 생산된 치료 당단백질 상의 n-글리코실화 부위 점유를 증가시키는 방법
|
EP2544785B1
(en)
*
|
2010-03-08 |
2015-09-30 |
GE Healthcare Bio-Sciences AB |
Immunoglobulin g fc region binding polypeptide
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
US9981017B2
(en)
|
2010-04-02 |
2018-05-29 |
Hanmi Science Co., Ltd. |
Insulin conjugate using an immunoglobulin fragment
|
AR081755A1
(es)
*
|
2010-04-02 |
2012-10-17 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
|
AR080993A1
(es)
*
|
2010-04-02 |
2012-05-30 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina
|
BR112012027765A2
(pt)
|
2010-04-30 |
2019-09-24 |
Enobia Pharma Inc |
métodos, composições e kits para tratamento de distúrbios de mineralização da matriz.
|
CA2800173C
(en)
*
|
2010-05-21 |
2019-05-14 |
Ulrik Nielsen |
Bi-specific fusion proteins
|
KR101330868B1
(ko)
*
|
2010-06-08 |
2013-11-18 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 인슐린 유도체 약물 결합체
|
KR20120002129A
(ko)
*
|
2010-06-30 |
2012-01-05 |
한미홀딩스 주식회사 |
면역글로불린 단편을 이용한 제7인자(Factor Ⅶa)약물 결합체
|
KR101337797B1
(ko)
*
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
KR101382593B1
(ko)
*
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
PL2598533T3
(pl)
|
2010-07-28 |
2019-07-31 |
Gliknik Inc. |
Białka fuzyjne naturalnych fragmentów białka ludzkiego do tworzenia uporządkowanych multimeryzowanych kompozycji Fc immunoglobulin
|
KR101333958B1
(ko)
*
|
2010-10-20 |
2013-11-27 |
주식회사 한독 |
인간 인터루킨-1 수용체 길항제-하이브리드 Fc 융합단백질
|
WO2012053828A2
(ko)
*
|
2010-10-20 |
2012-04-26 |
주식회사 한독약품 |
인간 인터루킨-1 수용체 길항제-하이브리드 Fc 융합단백질
|
KR101303388B1
(ko)
*
|
2010-10-26 |
2013-09-03 |
한미사이언스 주식회사 |
지속형 인터페론 알파 결합체의 액상 제제
|
EP2465536A1
(en)
|
2010-12-14 |
2012-06-20 |
CSL Behring AG |
CD89 activation in therapy
|
EP2655413B1
(en)
|
2010-12-23 |
2019-01-16 |
F.Hoffmann-La Roche Ag |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
EP2658979B1
(en)
|
2010-12-27 |
2018-02-14 |
Alexion Pharmaceuticals, Inc. |
Compositions comprising natriuretic peptides and methods of use thereof
|
AU2012205301B2
(en)
|
2011-01-14 |
2017-01-05 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
|
CN102309765B
(zh)
*
|
2011-02-28 |
2013-10-16 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段作为载体的长效抗凝多肽及其制备方法
|
CA2832581C
(en)
|
2011-04-08 |
2022-08-23 |
Yumei Xiong |
Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
|
UA113626C2
(xx)
*
|
2011-06-02 |
2017-02-27 |
|
Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
|
CN102807619B
(zh)
*
|
2011-06-03 |
2016-08-03 |
北京韩美药品有限公司 |
含有免疫球蛋白Fc片段和粒细胞-巨噬细胞集落刺激因子的复合物及其药物组合物
|
ES2692187T3
(es)
|
2011-06-10 |
2018-11-30 |
Hanmi Science Co., Ltd. |
Nuevos derivados de oxintomodulina y composición farmacéutica para el tratamiento de obesidad que lo comprende
|
KR101577734B1
(ko)
*
|
2011-06-17 |
2015-12-29 |
한미사이언스 주식회사 |
옥신토모듈린과 면역글로불린 단편을 포함하는 결합체 및 그의 용도
|
CA2839917A1
(en)
|
2011-06-24 |
2012-12-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
EP2726093A4
(en)
*
|
2011-06-28 |
2015-08-19 |
Inhibrx Llc |
WAP DOMAIN FUSION POLYPEPTIDES AND METHOD FOR THEIR USE
|
AU2012275287B2
(en)
*
|
2011-06-28 |
2017-10-05 |
Inhibrx, Inc. |
Serpin fusion polypeptides and methods of use thereof
|
RU2622077C2
(ru)
*
|
2011-09-05 |
2017-06-09 |
Ханми Сайенс Ко., Лтд. |
Фармацевтическая композиция для лечения рака, содержащая конъюгат интерферона-альфа
|
UY34347A
(es)
|
2011-09-26 |
2013-04-30 |
Novartis Ag |
Proteínas de función dual para tratar trastornos metabólicos
|
CN103974716B
(zh)
*
|
2011-10-06 |
2016-08-24 |
韩美科学株式会社 |
凝血因子Ⅶ和Ⅶa衍生物、包括其的缀合物和复合体及其用途
|
JP6158090B2
(ja)
*
|
2011-10-31 |
2017-07-05 |
ダニエル・ジェイ・カポン |
非ペプチドヒンジ部含有フレキシブル抗体様分子
|
KR20130049671A
(ko)
*
|
2011-11-04 |
2013-05-14 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
CN103172745A
(zh)
*
|
2011-12-21 |
2013-06-26 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段的长效人内皮抑素
|
KR102041412B1
(ko)
*
|
2011-12-30 |
2019-11-11 |
한미사이언스 주식회사 |
면역글로불린 Fc 단편 유도체
|
KR101895047B1
(ko)
*
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
CA2863224A1
(en)
|
2012-01-09 |
2013-07-18 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
AU2013208007A1
(en)
|
2012-01-09 |
2014-07-31 |
The Scripps Research Institute |
Humanized antibodies with ultralong CDR3
|
JP2015504675A
(ja)
|
2012-01-10 |
2015-02-16 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate |
アルファ−1アンチトリプシン融合分子の組成物、方法、及び使用
|
WO2013113008A1
(en)
|
2012-01-26 |
2013-08-01 |
Amgen Inc. |
Growth differentiation factor 15 (gdf-15) polypeptides
|
AR090281A1
(es)
|
2012-03-08 |
2014-10-29 |
Hanmi Science Co Ltd |
Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
|
EP2636681A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Process for enriching IgA
|
EP2636684A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Prevention of infection
|
BR112014022240A2
(pt)
|
2012-03-09 |
2017-08-01 |
Csl Behring Ag |
composições compreendendo imunoglobulinas semelhantes à secretoras
|
US10064951B2
(en)
|
2012-03-30 |
2018-09-04 |
Hanmi Science Co., Ltd. |
Liquid formulation of highly concentrated long-acting human growth hormone conjugate
|
KR102177252B1
(ko)
*
|
2012-04-23 |
2020-11-10 |
가부시키가이샤 에스 앤드 케이 바이오파마 |
락토페린 융합 단백질 및 그의 제조방법
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
AU2013270684B2
(en)
|
2012-06-08 |
2018-04-19 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
EP2863955B1
(en)
|
2012-06-26 |
2016-11-23 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
CA2871882A1
(en)
*
|
2012-06-27 |
2014-01-03 |
F. Hoffmann-La Roche Ag |
Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
|
CN104395339A
(zh)
|
2012-06-27 |
2015-03-04 |
弗·哈夫曼-拉罗切有限公司 |
用于选择并产生含有至少两种不同结合实体的定制高度选择性和多特异性靶向实体的方法及其用途
|
US10441665B2
(en)
|
2012-07-25 |
2019-10-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of long acting insulinotropic peptide conjugate
|
AR091902A1
(es)
|
2012-07-25 |
2015-03-11 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de un conjugado de insulina de accion prolongada
|
KR101968344B1
(ko)
|
2012-07-25 |
2019-04-12 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
|
AR092862A1
(es)
|
2012-07-25 |
2015-05-06 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de insulina de accion prolongada y un peptido insulinotropico y metodo de preparacion
|
AR094821A1
(es)
*
|
2012-07-25 |
2015-09-02 |
Hanmi Pharm Ind Co Ltd |
Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada
|
KR20150058236A
(ko)
|
2012-08-20 |
2015-05-28 |
글리크닉 인코포레이티드 |
항원 결합 및 다가 fc 감마 수용체 결합 활성을 가진 분자
|
JP6826367B2
(ja)
|
2012-08-31 |
2021-02-03 |
ストロ バイオファーマ インコーポレーテッド |
アジド基を含む修飾アミノ酸
|
KR20150052085A
(ko)
|
2012-09-14 |
2015-05-13 |
에프. 호프만-라 로슈 아게 |
2개 이상의 상이한 단위를 포함하는 분자의 제조 및 선별 방법, 및 이의 용도
|
WO2014043523A1
(en)
*
|
2012-09-14 |
2014-03-20 |
The Johns Hopkins University |
Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing
|
WO2014073842A1
(en)
|
2012-11-06 |
2014-05-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
|
KR101993393B1
(ko)
|
2012-11-06 |
2019-10-01 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
|
US9644021B2
(en)
|
2013-01-11 |
2017-05-09 |
The California Institute For Biomedical Research |
Bovine fusion antibodies
|
CN103217489B
(zh)
*
|
2013-01-15 |
2016-03-09 |
珠海市丽珠单抗生物技术有限公司 |
一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
|
KR102073748B1
(ko)
*
|
2013-01-31 |
2020-02-05 |
한미약품 주식회사 |
재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
|
EP2951205B1
(en)
|
2013-02-01 |
2021-08-11 |
Santa Maria Biotherapeutics, Inc. |
Anti-activin-a compounds for the treatment of ovarian cancer
|
EP2958581A1
(en)
*
|
2013-02-22 |
2015-12-30 |
Zoetis Services LLC |
In ovo administration of growth factors for improving poultry performance
|
JP6374412B2
(ja)
*
|
2013-03-05 |
2018-08-15 |
ハンミ ファーム.カンパニー リミテッドHanmi Pharm.Co.,Ltd. |
生理活性ポリペプチド結合体の高収率生産のための改善された製造方法
|
EP2970506A1
(en)
|
2013-03-11 |
2016-01-20 |
Novo Nordisk Health Care AG |
Growth hormone compounds
|
US20140271641A1
(en)
*
|
2013-03-14 |
2014-09-18 |
University Of Guelph |
Thrombospondin-1 polypeptides and methods of using same
|
US9587235B2
(en)
|
2013-03-15 |
2017-03-07 |
Atyr Pharma, Inc. |
Histidyl-tRNA synthetase-Fc conjugates
|
SG11201505926VA
(en)
|
2013-03-15 |
2015-09-29 |
Biogen Ma Inc |
Factor ix polypeptide formulations
|
KR101895634B1
(ko)
*
|
2013-05-31 |
2018-09-05 |
한미약품 주식회사 |
변이된 힌지 영역을 포함하는 IgG4 Fc 단편
|
EP3019522B1
(en)
|
2013-07-10 |
2017-12-13 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
AR096891A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
AR096890A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
|
CN105814074B
(zh)
|
2013-07-18 |
2020-04-21 |
图鲁斯生物科学有限责任公司 |
具有超长互补决定区的人源化抗体
|
EP3763734A1
(en)
*
|
2013-07-31 |
2021-01-13 |
Amgen Inc. |
Growth differentiation factor 15 (gdf-15) constructs
|
US20150093399A1
(en)
|
2013-08-28 |
2015-04-02 |
Bioasis Technologies, Inc. |
Cns-targeted conjugates having modified fc regions and methods of use thereof
|
EP3760639A1
(en)
|
2013-09-08 |
2021-01-06 |
Kodiak Sciences Inc. |
Zwitterionic polymer conjugates
|
DK3043810T3
(da)
|
2013-09-09 |
2020-01-27 |
Canimguide Therapeutics Ab |
Immunsystemsmodulatorer
|
CA2925416A1
(en)
|
2013-09-27 |
2015-04-02 |
Hanmi Pharm. Co., Ltd. |
Sustained type human growth hormone preparation
|
KR20160058952A
(ko)
*
|
2013-09-30 |
2016-05-25 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
에폭시화 지방 에스테르가 그 상에 배치된 섬유 및 와이프, 및 방법
|
PL3068797T3
(pl)
|
2013-11-11 |
2020-06-29 |
Wake Forest University Health Sciences |
Konstrukty wielowalentnego celowania w nowotwory
|
BR112016016578A2
(pt)
|
2014-01-20 |
2017-10-03 |
Hanmi Pharm Ind Co Ltd |
Insulina de ação prolongada e uso daanálogo de insulina, polinucleotídeo, vetor de expressão, transformante, insulina de ação prolongada bem como seu método de preparação e formulação da mesma, conjugado, e uso do mesmo mesma
|
WO2015112597A1
(en)
*
|
2014-01-21 |
2015-07-30 |
Belmont Biosciences, Inc. |
Variants of igg fc with limited amine groups that retain functional properties
|
CA2944138C
(en)
*
|
2014-03-31 |
2023-06-20 |
Hanmi Pharm. Co., Ltd. |
Method for improving solubility of protein and peptide by using immunoglobulin fc fragment linkage
|
AU2015243380B2
(en)
*
|
2014-04-11 |
2020-05-14 |
Medimmune, Llc |
Conjugated compounds comprising cysteine-engineered antibodies
|
CN106536548A
(zh)
*
|
2014-04-28 |
2017-03-22 |
国家生物技术研究所公司 |
Dr3变体及其用途
|
KR20150133576A
(ko)
*
|
2014-05-20 |
2015-11-30 |
삼성전자주식회사 |
화학적 개질된 표적화 단백질 및 그의 이용
|
AR100639A1
(es)
|
2014-05-29 |
2016-10-19 |
Hanmi Pharm Ind Co Ltd |
Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada
|
TWI684458B
(zh)
|
2014-05-30 |
2020-02-11 |
南韓商韓美藥品股份有限公司 |
包含胰島素及glp-1/昇糖素雙重促效劑之治療糖尿病之組成物
|
US10519234B2
(en)
|
2014-06-27 |
2019-12-31 |
Innate Pharma |
NKp46 binding proteins
|
US11208480B2
(en)
*
|
2014-06-27 |
2021-12-28 |
Innate Pharma |
Multispecific antigen binding proteins
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
WO2016014360A1
(en)
|
2014-07-24 |
2016-01-28 |
Genentech, Inc. |
Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
|
TWI802396B
(zh)
|
2014-09-16 |
2023-05-11 |
南韓商韓美藥品股份有限公司 |
長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
JP6849590B2
(ja)
*
|
2014-10-17 |
2021-03-24 |
コディアック サイエンシーズ インコーポレイテッドKodiak Sciences Inc. |
ブチリルコリンエステラーゼ両性イオン性ポリマーコンジュゲート
|
US10449236B2
(en)
|
2014-12-05 |
2019-10-22 |
Alexion Pharmaceuticals, Inc. |
Treating seizure with recombinant alkaline phosphatase
|
KR102418477B1
(ko)
|
2014-12-30 |
2022-07-08 |
한미약품 주식회사 |
글루카곤 유도체
|
EA035527B1
(ru)
|
2014-12-30 |
2020-06-30 |
Ханми Фарм. Ко., Лтд. |
Производные глюкагона с улучшенной стабильностью
|
CA2973883A1
(en)
|
2015-01-28 |
2016-08-04 |
Alexion Pharmaceuticals, Inc. |
Methods of treating a subject with an alkaline phosphatase deficiency
|
ES2853582T3
(es)
|
2015-03-06 |
2021-09-16 |
Canimguide Therapeutics Ab |
Moduladores del sistema inmune y composiciones
|
PT3280727T
(pt)
|
2015-04-06 |
2021-04-23 |
Acceleron Pharma Inc |
Proteínas de fusão do recetor de braço único do tipo i e tipo ii e respetivas utilizações
|
BR112017022658A2
(pt)
*
|
2015-04-22 |
2018-07-17 |
Alivegen Usa Inc |
proteína isolada, molécula de ácido nucleico isolada, vetor recombinante, célula hospedeira, método de produção de uma proteína actriib híbrida, composição farmacêutica, métodos de tratamentos de distúrbios relacionados à miostatina ou relacionados à ativina a, de doença de desgaste dos músculos, de doença cardiovascular, de distúrbios metabólicos, de células cancerígenas, de doença renal, de doença inflamatória/autoimune, de uma doença de fibrose, de anemia, da dor, da condição de envelhecimento, de distúrbios ósseos, de um desgaste dos músculos ou distúrbio metabólico ou fibrótico ou inflamatório ou relacionado à ativina em indivíduos, e, método de indução do crescimento das células-tronco para o reparo de tecido ou regeneração do órgão em um indivíduo
|
CA2979973A1
(en)
*
|
2015-04-29 |
2016-11-03 |
Mediolanum Farmaceutici S.P.A. |
A soluble chimeric interleukin-10 receptor and therapeutic use thereof
|
EP3303380B1
(en)
|
2015-06-02 |
2020-01-15 |
Novo Nordisk A/S |
Insulins with polar recombinant extensions
|
AU2016274890B2
(en)
*
|
2015-06-12 |
2022-02-10 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
US11820807B2
(en)
*
|
2015-06-12 |
2023-11-21 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
CA2990518A1
(en)
|
2015-06-23 |
2016-12-29 |
Innate Pharma |
Multispecific nk engager proteins
|
PE20240215A1
(es)
*
|
2015-06-30 |
2024-02-16 |
Hanmi Pharmaceutical Co Ltd |
Derivado de glucagon y una composicion que comprende un conjugado de accion prolongada del mismo
|
EP3325496B1
(en)
|
2015-07-24 |
2024-02-07 |
Hanmi Pharm. Co., Ltd. |
Method of preparing physiologically active polypeptide conjugate
|
US11352612B2
(en)
|
2015-08-17 |
2022-06-07 |
Alexion Pharmaceuticals, Inc. |
Manufacturing of alkaline phosphatases
|
UY36870A
(es)
|
2015-08-28 |
2017-03-31 |
Hanmi Pharm Ind Co Ltd |
Análogos de insulina novedosos
|
SG10202002577XA
(en)
|
2015-09-21 |
2020-04-29 |
Aptevo Res & Development Llc |
Cd3 binding polypeptides
|
WO2017052329A1
(en)
|
2015-09-24 |
2017-03-30 |
Hanmi Pharm. Co., Ltd. |
Protein complex by use of a specific site of an immunoglobulin fragment for linkage
|
TW201718629A
(zh)
*
|
2015-09-25 |
2017-06-01 |
韓美藥品股份有限公司 |
包含多個生理多肽及免疫球蛋白Fc區之蛋白質接合物
|
WO2017058822A1
(en)
|
2015-09-28 |
2017-04-06 |
Alexion Pharmaceuticals, Inc. |
Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
|
MA43348A
(fr)
|
2015-10-01 |
2018-08-08 |
Novo Nordisk As |
Conjugués de protéines
|
JP6981973B2
(ja)
|
2015-10-01 |
2021-12-17 |
ヒート バイオロジクス,インコーポレイテッド |
I型及びii型細胞外ドメインを異種キメラタンパク質として連結する組成物及び方法
|
US10040840B2
(en)
*
|
2015-10-02 |
2018-08-07 |
Silver Creek Pharmaceuticals, Inc. |
Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
|
US20170095577A1
(en)
*
|
2015-10-06 |
2017-04-06 |
Washington University |
Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography
|
EP3368062A4
(en)
|
2015-10-30 |
2019-07-03 |
Alexion Pharmaceuticals, Inc. |
METHODS OF TREATING CRANIOSYNOSTOSIS IN A PATIENT
|
CN108430511B
(zh)
*
|
2015-12-21 |
2021-06-04 |
合肥立方制药股份有限公司 |
一种药物设计方法和获得的药物及其应用
|
IL260323B1
(en)
|
2015-12-30 |
2024-09-01 |
Kodiak Sciences Inc |
Antibodies and their conjugates
|
KR20170079409A
(ko)
*
|
2015-12-30 |
2017-07-10 |
한미약품 주식회사 |
지속형 인간 성장 호르몬 결합체의 신규 액상 제제
|
KR20170080521A
(ko)
|
2015-12-31 |
2017-07-10 |
한미약품 주식회사 |
글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체
|
CN114796520A
(zh)
|
2016-01-27 |
2022-07-29 |
苏特罗生物制药公司 |
抗cd74抗体偶联物,包含抗cd74抗体偶联物的组合物以及抗cd74抗体偶联物的使用方法
|
AR107483A1
(es)
*
|
2016-01-29 |
2018-05-02 |
Hanmi Pharm Ind Co Ltd |
Conjugado de enzimas terapéuticas
|
WO2017155569A1
(en)
|
2016-03-08 |
2017-09-14 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
WO2017173395A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
CA3019726A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Treating muscle weakness with alkaline phosphatases
|
US11208632B2
(en)
|
2016-04-26 |
2021-12-28 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
EP3453758A4
(en)
|
2016-05-02 |
2019-12-04 |
Ajinomoto Co., Inc. |
FC PROTEIN WITH AZID GROUP
|
CN106008722B
(zh)
*
|
2016-05-13 |
2019-10-15 |
未名生物医药有限公司 |
一种重组β-hNGF-Fc融合蛋白、制备方法及用途
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
US11034775B2
(en)
|
2016-06-07 |
2021-06-15 |
Gliknik Inc. |
Cysteine-optimized stradomers
|
IL263934B2
(en)
|
2016-06-29 |
2023-10-01 |
Hanmi Pharm Ind Co Ltd |
A derivative of glucagon, its conjugate, a preparation containing it and its medical use
|
EP3500289B1
(en)
|
2016-08-18 |
2024-10-09 |
Alexion Pharmaceuticals, Inc. |
Asfotase alfa for use in treating tracheobronchomalacia
|
JOP20190019A1
(ar)
*
|
2016-08-30 |
2019-02-12 |
Genexine Inc |
تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH)
|
EP3517544A4
(en)
|
2016-09-23 |
2020-06-03 |
Hanmi Pharm. Co., Ltd. |
INSULIN ANALOG HAVING REDUCED INSULIN RECEPTOR BINDING FORCE AND USE THEREOF
|
CN110291103A
(zh)
*
|
2016-12-05 |
2019-09-27 |
韩美药品株式会社 |
具有弱化的免疫应答的缀合物
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
AU2017371179B2
(en)
|
2016-12-09 |
2022-07-14 |
Gliknik Inc. |
Manufacturing optimization of GL-2045, a multimerizing stradomer
|
BR112019016077A2
(pt)
*
|
2017-02-03 |
2020-03-31 |
Hanmi Pharm. Co., Ltd. |
Conjugado da fórmula 1, método para preparar o conjugado, preparação de atuação longa, preparação para prevenir ou tratar diabetes e método para tratar diabetes
|
CN110381983B
(zh)
|
2017-02-27 |
2024-07-09 |
沙塔克实验室有限公司 |
基于tigit和light的嵌合蛋白
|
CN110381974A
(zh)
|
2017-02-27 |
2019-10-25 |
沙塔克实验室有限公司 |
基于csf1r的嵌合蛋白
|
EP3604328A4
(en)
|
2017-03-23 |
2021-01-06 |
Hanmi Pharm. Co., Ltd. |
REDUCED INSULIN ANALOGUE COMPLEX FOR INSULIN RECEPTOR AND ITS USE
|
CN110719786A
(zh)
|
2017-03-31 |
2020-01-21 |
阿雷克森制药公司 |
用于治疗成人和青少年的低磷酸酯酶症(hpp)的方法
|
MA49339A
(fr)
*
|
2017-04-05 |
2020-02-12 |
Novo Nordisk As |
Conjugués insuline-fc à extension oligomère
|
WO2018193033A1
(en)
*
|
2017-04-20 |
2018-10-25 |
Novo Nordisk A/S |
Methods of purification of albumin fusion proteins
|
AU2018256435A1
(en)
|
2017-04-20 |
2019-11-07 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
CN109206522B
(zh)
*
|
2017-07-07 |
2021-11-09 |
北京三有利和泽生物科技有限公司 |
一种长效抗凝血融合蛋白及其应用
|
JP6566324B2
(ja)
*
|
2017-09-29 |
2019-08-28 |
サイデン化学株式会社 |
粘着シート
|
WO2019066603A1
(ko)
|
2017-09-29 |
2019-04-04 |
한미약품 주식회사 |
효력이 향상된 지속성 단백질 결합체
|
CR20200129A
(es)
|
2017-10-02 |
2020-08-22 |
Denali Therapeutics Inc |
Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas
|
KR102167827B1
(ko)
*
|
2017-12-20 |
2020-10-20 |
주식회사 알테오젠 |
신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질
|
CN108218998A
(zh)
*
|
2017-12-31 |
2018-06-29 |
武汉班科生物技术股份有限公司 |
一种突变型人源IgG的Fc片段及其制备方法与应用
|
KR101974305B1
(ko)
*
|
2018-02-14 |
2019-04-30 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
US12071476B2
(en)
|
2018-03-02 |
2024-08-27 |
Kodiak Sciences Inc. |
IL-6 antibodies and fusion constructs and conjugates thereof
|
IL314733A
(en)
*
|
2018-03-26 |
2024-10-01 |
Regeneron Pharma |
Humanized rodents for testing therapeutic agents
|
KR102209108B1
(ko)
|
2018-03-27 |
2021-01-28 |
국립암센터 |
Oct4 기능 저해용 펩티드를 포함하는 줄기세포성 억제용 조성물
|
EP3773684A1
(en)
|
2018-03-30 |
2021-02-17 |
Alexion Pharmaceuticals, Inc. |
Manufacturing of glycoproteins
|
CN111954537A
(zh)
|
2018-04-09 |
2020-11-17 |
美国安进公司 |
生长分化因子15融合蛋白
|
US10780121B2
(en)
|
2018-08-29 |
2020-09-22 |
Shattuck Labs, Inc. |
FLT3L-based chimeric proteins
|
AU2020260931B2
(en)
*
|
2019-04-23 |
2023-08-24 |
Lg Chem, Ltd. |
Fusion polypeptide comprising Fc region of immunoglobulin and GDF15
|
US11267858B2
(en)
*
|
2019-05-31 |
2022-03-08 |
Spectrum Pharmaceuticals, Inc. |
Methods of treatment using G-CSF protein complex
|
CN112142850A
(zh)
*
|
2019-06-27 |
2020-12-29 |
深圳市卫光生物制品股份有限公司 |
人神经生长因子-乳铁蛋白重组蛋白及用途
|
US11912784B2
(en)
|
2019-10-10 |
2024-02-27 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
CN110669134A
(zh)
*
|
2019-10-15 |
2020-01-10 |
广东菲鹏生物有限公司 |
IgM-FC片段、IgM-FC抗体及制备方法和应用
|
MX2022006634A
(es)
*
|
2019-12-11 |
2022-07-04 |
Lg Chemical Ltd |
Polipeptido de fusion que comprende gdf15 y region de polipeptido capaz de experimentar o-glicosilacion.
|
CN111153996B
(zh)
*
|
2020-01-10 |
2021-12-14 |
苏州睿瀛生物技术有限公司 |
G蛋白偶联受体的抗体及其制备方法和g蛋白偶联受体试剂盒
|
CN111505291B
(zh)
*
|
2020-04-14 |
2023-04-25 |
山东省千佛山医院 |
一种排除巨酶分子对血清酶浓度检测带来干扰的方法
|
KR20210144608A
(ko)
|
2020-05-22 |
2021-11-30 |
한미약품 주식회사 |
액상 제제
|
CN112098639B
(zh)
*
|
2020-09-21 |
2024-01-02 |
天津医科大学 |
以氧化石墨烯为载体的二抗的合成及应用
|
CA3173631A1
(en)
|
2021-02-12 |
2022-08-18 |
Walter C. Voegtli |
Alkaline phosphatase polypeptides and methods of use thereof
|
AU2023213963A1
(en)
*
|
2022-01-28 |
2024-07-18 |
argenx BV |
Anti-musk antibodies for use in treating neuromuscular disorders
|
IL315251A
(en)
*
|
2022-03-03 |
2024-10-01 |
Univ Pennsylvania |
Viral vectors encoding parathyroid hormone fusions and their uses for the treatment of hypoparathyroidism
|
CN114588315A
(zh)
*
|
2022-03-14 |
2022-06-07 |
东莞市人民医院 |
抗炎蛋白涂层的制备方法、生物工程功能材料及其应用
|
WO2024123675A2
(en)
*
|
2022-12-05 |
2024-06-13 |
Alexion Pharmaceuticals, Inc. |
Taci-fc fusion proteins for multifunctional inhibition of baff, april, and neonatal fc receptor
|
WO2024148243A1
(en)
|
2023-01-06 |
2024-07-11 |
Lassen Therapeutics 1, Inc. |
Anti-il-18bp antibodies
|
WO2024148241A1
(en)
|
2023-01-06 |
2024-07-11 |
Lassen Therapeutics 1, Inc. |
Anti-il-18bp antibodies
|
WO2024148240A1
(en)
|
2023-01-06 |
2024-07-11 |
Lassen Therapeutics 1, Inc. |
ANTI-IL-11Rα ANTIBODIES FOR TREATING THYROID EYE DISEASE
|